Goldman Sachs Agents Hologic Facility Amendment
Hologic announced that it completed a re-pricing of its senior secured tranche B term loan facility under the company’s credit and guaranty agreement dated August 1, 2012.
Goldman Sachs Bank USA served as administrative and collateral agent in the facility refinancing.
The amendment refinances the company’s existing term loan B with a maturity date of August 1, 2019, resulting in a 75 basis point reduction in the interest rate (from 3.50% plus LIBOR with a 1.00% floor to 2.75% plus LIBOR with a 1.00% floor).
In conjunction with the refinancing, it also amends certain of the covenants in the credit agreement to increase the company’s capacity to repurchase shares of its common stock and issue dividends. The company increased its general restricted junior payments basket to $250 million (from $25 million) and increased the total net leverage allowable to 4.0x (from 3.5x) for directing unused excess cash flow for restricted junior payments. In addition, the company voluntarily prepaid $200 million of the term loan B on August 2, 2013.
Hologic is a developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women.